CoA – Synagis | Palivizumab | RSV protein F | 382291

150,00 

Certificate of Analysis (CoA) is an official document issued by the manufacturer of the medicinal product. It contains information on some critical quality characteristics of the medicine. CoA’s are available only for some medicines and limited batches. Customers can order the medicinal product CoA together with the aliquots of the same batch.

Additional information

Original Manufacturer

AbbVie Deutschland GmbH & Co. KG

Batch Number

382291

Original therapeutic expiry date [see Note 1]

04/2019